Search research articles
Contact Us
Filters
Showing results (61-70 of 102) with videos related to
Page
of 11
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 20, 2016
Efficacy of a combination of high and low dosage of PEGylated FGF-21 in treatment of diabetes in db/db mice
Pengfei Xu, Yingjie Zhang, Liying Song, et al.
EXCLI Journal
|
June 3, 2020
Fibroblast Growth Factor-21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells
Yeboah Kwaku Opoku, Zhihang Liu, Justice Afrifa, et al.
Current Pharmaceutical Biotechnology
|
July 7, 2015
Isolation of the neutralization ScFvs Against HBV infection from the Immunized Population
Yin Bai, Yanmin Chen, Nan Zhang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 31, 2023
Evaluation of prevention and treatment effects of fibroblast growth factor-21 in BLM-induced pulmonary fibrosis
Xiangxiang Wang, Shuang Li, Jinmiao Liu, et al.
Inflammation
|
April 20, 2021
An immuno-blocking agent targeting IL-1β and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice
Qi Yin, Xuelei Pi, Yuanyuan Jiang, et al.
Veterinary Microbiology
|
December 30, 2018
The composite biological adjuvants enhance immune response of porcine circovirus type2 vaccine
Xiaochen Guo, Qi Zheng, Xinghao Jiang, et al.
Technology in Cancer Research & Treatment
|
August 26, 2015
Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy
Guiping Ren, Guiyou Tian, Yunye Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 2, 2017
A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis
Yunxin Wang, Qiang Wu, Zhihang Liu, et al.
Endocrine
|
November 27, 2015
Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway
Dan Yu, Xianlong Ye, Qiang Wu, et al.
International Immunopharmacology
|
June 9, 2016
Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-κB signaling pathway
Yinhang Yu, Jinjiao He, Siming Li, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 102) with videos related to
Sort By:
Page
of 11
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 20, 2016
Efficacy of a combination of high and low dosage of PEGylated FGF-21 in treatment of diabetes in db/db mice
Pengfei Xu, Yingjie Zhang, Liying Song, et al.
EXCLI Journal
|
June 3, 2020
Fibroblast Growth Factor-21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells
Yeboah Kwaku Opoku, Zhihang Liu, Justice Afrifa, et al.
Current Pharmaceutical Biotechnology
|
July 7, 2015
Isolation of the neutralization ScFvs Against HBV infection from the Immunized Population
Yin Bai, Yanmin Chen, Nan Zhang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 31, 2023
Evaluation of prevention and treatment effects of fibroblast growth factor-21 in BLM-induced pulmonary fibrosis
Xiangxiang Wang, Shuang Li, Jinmiao Liu, et al.
Inflammation
|
April 20, 2021
An immuno-blocking agent targeting IL-1β and IL-17A reduces the lesion of DSS-induced ulcerative colitis in mice
Qi Yin, Xuelei Pi, Yuanyuan Jiang, et al.
Veterinary Microbiology
|
December 30, 2018
The composite biological adjuvants enhance immune response of porcine circovirus type2 vaccine
Xiaochen Guo, Qi Zheng, Xinghao Jiang, et al.
Technology in Cancer Research & Treatment
|
August 26, 2015
Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy
Guiping Ren, Guiyou Tian, Yunye Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 2, 2017
A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis
Yunxin Wang, Qiang Wu, Zhihang Liu, et al.
Endocrine
|
November 27, 2015
Insulin sensitizes FGF21 in glucose and lipid metabolisms via activating common AKT pathway
Dan Yu, Xianlong Ye, Qiang Wu, et al.
International Immunopharmacology
|
June 9, 2016
Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-κB signaling pathway
Yinhang Yu, Jinjiao He, Siming Li, et al.
Page
of 11